Description
Quick-Reference Overview Matrix
For efficient laboratory evaluation, the matrix below consolidates the core analytical, storage, and cross-reference parameters of Semax / Selank Blend 5/5mg.
| Core Parameter | Technical Summary & Quick Data | Internal Cross-Reference |
|---|---|---|
| Purity & Ratio | ≥ 98% HPLC Certified Precise 1:1 molar ratio stabilization (5mg Semax / 5mg Selank) in a single freeze-dried cake. | View High-Purity Series → |
| Primary Target Path | Neuro-Modulatory Sinergy: Combined ACTH/Tuftsin receptor agonism targeting BDNF/NGF synthesis and GABAergic/monoamine balance. | Nootropic Research Series → |
| Storage Protocol | Lyophilized: -20°C to -80°C (Up to 24 months). Reconstituted: 2°C to 8°C (Must use within 10–14 days). | Buy Reconstitution Diluents → |
| Synergistic Assays | Frequently co-evaluated alongside regulatory bioenergetics or cellular longevity compounds to map broad neuro-adaptive responses. | Pair with Peptides Blends → |
What Is the Semax / Selank Blend?
What Is the Semax / Selank Blend?
The Semax / Selank Blend combines two prominent synthetic regulatory oligopeptides into a single, structurally unified matrix. Semax is a heptapeptide analog of the Adrenocorticotropic Hormone (ACTH 4-10 fragment), heavily studied for its brain-derived neurotrophic factor (BDNF) upregulating properties. Selank is a synthetic heptapeptide analog of the naturally occurring immunomodulatory peptide Tuftsin, incorporating a Pro-Gly-Pro sequence to enhance enzymatic stability. This formulation allows researchers to examine the parallel activation of neuro-regenerative and anxiolytic pathways in a unified laboratory model.
Product Composition & Overview
Our Semax / Selank Blend 5/5mg provides an elite, analytical-grade combination (10mg total active compound per vial) freeze-dried under strict vacuum metrics. This precise 1:1 structural pairing guarantees uniform ratio extraction when prepping in vitro and in vivo neurological assay setups.
| Parameter | Specification |
|---|---|
| Product Format | 10mg Total Blend Vial (5mg Semax / 5mg Selank) |
| Semax Sequence | Met-Glu-His-Phe-Pro-Gly-Pro |
| Selank Sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro |
| Purity Level | ≥ 98% Combined (HPLC Verified) |
| Physical Appearance | Sterile filtered, white lyophilized cake |
| Core Research Focus | BDNF/NGF Gene Expression, Enkephalin Degradation Inhibition, Monoaminergic Neurotransmission Mapping |
Regulatory Compliance Notice: This product is synthesized, distributed, and intended solely for laboratory research and development purposes. It is strictly not for human therapeutic use, clinical trials, or agricultural applications. Analytical certification profiles are logged per batch.
Research Applications of the Semax / Selank Sinergy
Research Applications of the Semax / Selank Sinergy
In contemporary neurobiology, this blend is evaluated across adaptive stress, cellular survival, and neurotransmitter homeostatic models. Researchers utilize this compound to analyze:
- Neurotrophic Amplification: Studying the parallel upregulation of Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF) in hippocampal structures.
- Enkephalin Longevity: Investigating Selank’s capacity to inhibit enzymes responsible for breaking down endogenous enkephalins, thereby examining intrinsic emotional processing paths.
- Nootropic Transcription Paths: Tracking changes in mRNA expressions regulating synaptic plasticity and neurovascular adaptations during experimental oxygen stress assays.
Mechanism of Action Breakdown
The Semax / Selank Blend operates through distinct but overlapping pathways within central nervous system tissue matrices:
- Semax Pathway: Modulates melanocortin receptors (primarily MC4) independent of hormonal activity, triggering localized release of neurotrophins that support neuronal survival and axonal outgrowth.
- Selank Pathway: Alters monoamine neurotransmitter metabolism (serotonin and dopamine paths) while interacting with the GABAergic system to stabilize neural firing without inducing sedation artifacts.
- Sinergistic Outcome: The dual presence mitigates oxidative cellular damage inside brain structures while optimizing signaling integrity across synaptic junctions.
Research Overview: Benefits vs. Technical Risks
| Observed Research Benefits | Technical Risks & Limitations |
|---|---|
| • Multi-Target Tracking: Allows simultaneous collection of data regarding both stimulatory nootropic and inhibitory anxiolytic tracks in a single study. | • Dual Degradation Vectors: Because two distinct sequences are present in the solution, enzymatic cleavage tracking requires careful protease-free assay environments. |
| • Pro-Gly-Pro Stability: Both sequences contain protective proline-glycine clusters, providing improved resilience against early baseline hydrolysis paths. | • Biphasic Assay Interference: Incorrectly calculated concentration loads can cause overlapping signaling readouts, obscuring clear data distinction. |
Peptide Comparison Matrix
Peptide Comparison Matrix
To optimize experimental setups, the comparison matrix below differentiates the Semax / Selank Blend from single-sequence nootropic and regulatory research peptides in our catalog:
| Peptide Compound | Primary Mechanism | Core Research Focus | Target Receptors | Molecular Status |
|---|---|---|---|---|
| Semax / Selank Blend(This Product) | Dual ACTH/Tuftsin Matrix | Synergistic BDNF upregulation, cognitive modeling, and monoamine balancing. | MC4 / GABA / Enkephalin | 5mg + 5mg Dual Formulation |
| Epitalon 50mg | Telomerase Inducer | Cellular lifespan tracking, telomere repair, circadian rhythm modeling. | Epigenetic DNA | 390.4 g/mol |
| Thymosin Alpha-1 | Immune Modulator | T-cell differentiation tracking, neuro-immune axis evaluation. | TLR2 / TLR9 | 3108.3 g/mol |
Storage & Handling Instructions
Storage & Handling Instructions
To avoid premature amino acid cleavage and preserve the strict 1:1 molar distribution of the blend, strictly observe the following laboratory climate protocols:
- LONG-TERM Lyophilized State: Store at -20°C or -80°C. Under deep freezing conditions, the structural composition remains secure for up to 24 months.
- SHORT-TERM Transit Stability: The freeze-dried blend cake resists ambient temperature fluctuations up to 25°C for 3 weeks max during shipment. Freeze upon arrival.
- POST-RECONSTITUTION Solubilized State: Store inside laboratory refrigeration between 2°C and 8°C. Exhaust the testing solution completely within 10–14 days. Do not agitate or refreeze.
Reconstitution Guidelines
- Allow the dual peptide vial to reach room temperature equilibrium naturally before opening.
- Sanitize the top rubber entry septa interface with a fresh isopropyl sterile swab.
- Slowly slide 1ml to 2ml of sterile bacteriostatic water down the inside glass barrier to limit mechanical stress factors.
- Do not shake. Gently swirl the vial horizontally in circular paths until the 10mg mixed cake transitions fully into a clear, residue-free liquid phase.
There are no reviews yet.